#Biosimilars offer an opportunity to help reduce total biologic drug spend. They could save between $54 to $250 bn over their first 10 years on the market. According to a recent estimate, there are more than 1000 biosimilars in any stage of the pipelinehttps://www.pharmacytimes.com/news/overview-of-the-biosimilar-landscape …
0 replies
0 proslijeđenih tweetova
1 korisnik označava da mu se sviđa
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.